Immunocore Holdings plc Income Statement

Income Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 30.11M36.48M174.36M249.43M310.20M
Cost of Revenue 1.09M1.04M2.73M
Gross Profit 173.27M248.39M307.47M
Operating items
Research & Development -74.81M100.25M101.92M163.54M222.15M
Selling, General & Administrative -45.74M110.82M123.06M144.50M155.78M
Operating Expenses -120.55M211.07M224.98M308.04M377.93M
Operating Income 4.24M-174.59M-51.71M-59.65M-70.46M
EBIT 4.24M-174.59M-51.71M-59.65M-70.46M
Non-operating items
Interest & Investment Income 2.21M0.07M3.76M17.99M25.62M
Other Non Operating Income 0.29M14.16M-13.18M14.20M
Non Operating Income -1.17M-0.07M-1.68M-0.90M14.20M
Net income details
EBT -87.36M-179.88M-40.88M-60.89M-52.94M
Tax Provisions -0.24M11.66M-5.60M-1.85M
Profit After Tax -74.09M-180.03M-52.54M-55.29M-51.09M
Income from Continuing Operations -87.36M-179.64M-52.54M-55.29M-51.09M
Consolidated Net Income -87.36M-179.64M-52.54M-55.29M-51.09M
Income towards Parent Company -87.36M-179.64M-52.54M-55.29M-51.09M
Net Income towards Common Stockholders -87.36M-179.64M-52.54M-55.29M-51.09M
Additional items
EPS (Basic) -2.14-4.24-1.15-1.13-1.02
EPS (Weighted Average and Diluted) -4.24-1.15-1.13-1.02
Shares Outstanding (Weighted Average) 40.74M43.86M47.90M49.44M50.03M
Shares Outstanding (Diluted Average) 48.89M49.99M
EBITDA 4.24M-180.28M-76.90M-36.88M-48.59M
Interest Expenses -3.38M5.57M5.41M5.15M18.84M
Tax Rate 0.14%9.20%3.49%